PATENT CLAIM ANALYSIS

Application Number: 15912074
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "235200"]

Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Claim (Index 71):
The method of  claim 54 , wherein the compound, the pharmaceutically acceptable salt thereof, or the pharmaceutical composition comprising said compound or pharmaceutically acceptable salt thereof, is comprised in a tablet.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14515793', '14205508', '14205657', '15426150', '15133378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7771256363085024
- 35 USC 102 Novelty (BERT): 0.5612041619701736
- Combined Prediction Score: 0.7555334888746695
- Mean Citation Score: 374.634704
- Max Citation Score: 457.66522
- Similarity Product: 311.4025418722856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test